Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cytokinetics, Incorporated (CYTK)

« Back to company index

CYTK Chatter Timeline

Stock Ticker for CYTK

Most Active Tweeters for CYTK

UserTweets
@1MinuteStock 7
@AmericanBanking 5
@livetraderalrt 5
@registrarjourn 4
@Allstocknews 3

Recent Tweets for CYTK

dklndt @dklndt
@adamfeuerstein $CYTK is a long term thesis for a heart failure. Reldesemtiv is a side show that is not decisive one way or another.
June 18th 2018, 7:06pm
dakotafinancial @dakotafinancial
Cytokinetics $CYTK Trading Down 16.7% Following Analyst Downgrade https://t.co/PcbHlS52Fy
June 18th 2018, 7:06pm
registrarjourn @registrarjourn
Cytokinetics $CYTK Stock Price Down 16.7% Following Analyst Downgrade https://t.co/QQL9A1zbnf
June 18th 2018, 7:06pm
rleuty_biotech @rleuty_biotech
RT @adamfeuerstein: $CYTK -15% on some really mediocre SMA data presented over the weekend. Squint hard and you might see some benefit in a…
June 18th 2018, 6:06pm
BioPharmaDive @BioPharmaDive
Though a study investigator called the results encouraging, shares in the company slid 15% Monday morning https://t.co/Kyh7MyZO4R $CYTK
June 18th 2018, 5:06pm
IlliniJJ @IlliniJJ
$CYTK - bought initial position at $8.05, sell off seemed too drastic.
June 18th 2018, 4:06pm
AmericanBanking @AmericanBanking
Cytokinetics $CYTK Price Target Cut to $13.00 by Analysts at Piper Jaffray Companies https://t.co/8q0QVUcjpr #stocks
June 18th 2018, 3:06pm
hiropoppon21 @hiropoppon21
RT @JohnCendpts: $CYTK down 17% today. Beware failed p values, people. You own it. https://t.co/8aUFZO0WWk
June 18th 2018, 3:06pm
RNAiAnalyst @RNAiAnalyst
$CYTK in its long history, has Co ever had a clear-cut clinical win?
June 18th 2018, 3:06pm
JohnCendpts @JohnCendpts
$CYTK down 17% today. Beware failed p values, people. You own it. https://t.co/8aUFZO0WWk
June 18th 2018, 3:06pm
BioPharmaDive @BioPharmaDive
Cytokinetics says early SMA treatment shows promise https://t.co/Kyh7Mzhptr $CYTK
June 18th 2018, 1:06pm
TCWReporter @TCWReporter
Stock drop: $CYTK and 5 other stocks drop. The Common Wealth is investigating! Reach out for more info. TheCommonWe… https://t.co/DYoBOj1h83
June 18th 2018, 1:06pm
adamfeuerstein @adamfeuerstein
$CYTK -15% on some really mediocre SMA data presented over the weekend. Squint hard and you might see some benefit… https://t.co/fWK65hpcqb
June 18th 2018, 12:06pm
BenzingaMedia @BenzingaMedia
$CYTK, $INTC 42 Stocks Moving In Monday's Mid-Day Session - https://t.co/dHINjAXR0Q
June 18th 2018, 12:06pm
StockMatusow @StockMatusow
Totally disagree with market's beating down $CYTK. Data is a positive early indicator. More work needs to be done,… https://t.co/WYYdbxLvQF
June 18th 2018, 12:06pm
IlliniJJ @IlliniJJ
$CYTK - watching it down here, looks like support $8.20, no position yet, but considering.
June 18th 2018, 11:06am
registrarjourn @registrarjourn
Cytokinetics $CYTK Price Target Increased to $24.00 by Analysts at HC Wainwright https://t.co/bt4bWbKFcs
June 18th 2018, 11:06am
QuantchaIdeas @QuantchaIdeas
Big Loser Alert: Trading today’s -8.1% move in CYTOKINETICS INCORPORATED COM $CYTK https://t.co/aE0X455Cfo https://t.co/Vzzc7glJrb
June 18th 2018, 10:06am
RolfeNeelsen @RolfeNeelsen
$CYTK See if $8 holds this week...
June 18th 2018, 9:06am
dakotafinancial @dakotafinancial
Cytokinetics $CYTK Price Target Lowered to $13.00 at Piper Jaffray Companies https://t.co/vZ9SXo3IfD
June 18th 2018, 9:06am
Briefingcom @Briefingcom
$CYTK: Cytokinetics presents Phase 2 data for Reldesemtiv; showed potentially clinically meaningful effects https://t.co/qvADrExtQE
June 18th 2018, 8:06am
RatingsNetwork @RatingsNetwork
Cytokinetics's PT cut by Piper Jaffray Companies to $13.00. overweight rating. https://t.co/KLX8gmfAXP $CYTK #CYTK
June 18th 2018, 8:06am
AmericanBanking @AmericanBanking
Cytokinetics’ $CYTK “Hold” Rating Reaffirmed at Cantor Fitzgerald https://t.co/cBjMtbbUOk #stocks
June 17th 2018, 9:06pm
ConsumerFeed @ConsumerFeed
Cytokinetics's hold rating reiterated at Cantor Fitzgerald. $10.00 PT. https://t.co/pPEIriCFJn $CYTK #CYTK
June 17th 2018, 9:06pm
RatingsNetwork @RatingsNetwork
Cytokinetics's hold rating reiterated at Cantor Fitzgerald. $10.00 PT. https://t.co/bCzhJEFuQ6 $CYTK #CYTK
June 17th 2018, 9:06pm
ARatings @ARatings
Cantor Fitzgerald Sticks to Its Hold Rating for Cytokinetics Inc $CYTK https://t.co/igctLOCkcL
June 17th 2018, 8:06pm
TranscriptDaily @TranscriptDaily
Analysts Expect Cytokinetics $CYTK Will Announce Earnings of -$0.51 Per Share https://t.co/DryRk9yqDG
June 17th 2018, 10:06am
StockMatusow @StockMatusow
$CYTK reported good early data in SMA in the high 450 dose. Should see stock do well come Monday .. Company has a c… https://t.co/XYbli4qGFe
June 16th 2018, 10:06pm
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $CYTK? The Short Ratio is 11.71% https://t.co/zewZCIJde7
June 16th 2018, 10:06pm
1MinuteStock @1MinuteStock
Do you know that #Book Value for $CYTK is $1.84 https://t.co/Qxi9laU5bq
June 16th 2018, 9:06pm
1MinuteStock @1MinuteStock
Recommendation #HOLD for $CYTK with UB rating - 2.69 out of 5. https://t.co/EwdsbFcN4C
June 16th 2018, 7:06pm
AnthemTrading @AnthemTrading
$CYTK (9.90) Weekend data on reldesemtiv looks pretty good for an early study in SMA. Dose dependent and close to s… https://t.co/DvhMcV33Br
June 16th 2018, 6:06pm
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $CYTK for you: 17.8% https://t.co/ANdISJBylL
June 16th 2018, 3:06pm
jtraderco @jtraderco
RT @odibro: $CYTK Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With #SMA at the 2018 Annual Cure SMA Conference ht…
June 16th 2018, 2:06pm
1MinuteStock @1MinuteStock
Not sure what to do with $CYTK? Explore our #fundamental pros and cons. https://t.co/37KXe1jmD9
June 16th 2018, 2:06pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $CYTK is $-0.7 it's -7.07% of the current price https://t.co/NFI63TP3Sf
June 16th 2018, 1:06pm
odibro @odibro
$CYTK Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With #SMA at the 2018 Annual Cure SMA C… https://t.co/iDwwGW5xod
June 16th 2018, 12:06pm
GNWLive @GNWLive
Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular $CYTK https://t.co/nmvim00ewa
June 16th 2018, 11:06am
livetraderalrt @livetraderalrt
$CYTK 0.6m ago: Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Mus… https://t.co/mvYvmU2WYP
June 16th 2018, 11:06am
Allstocknews @Allstocknews
$CYTK Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscula From our Stock News Alerts App
June 16th 2018, 11:06am
BlastarTrader @BlastarTrader
Cytokinetics to Present at the JMP Securities Life Sciences Conference $CYTK https://t.co/1hM0CAiOPI
June 16th 2018, 11:06am
reurope_stock @reurope_stock
How Many Cytokinetics, Incorporated $CYTK's Analysts Are Bullish? https://t.co/kRsw38v9Wo
June 16th 2018, 6:06am
WeekHerald @WeekHerald
Cytokinetics $CYTK Expected to Post Quarterly Sales of $5.57 Million https://t.co/tRaxfXpQIO
June 16th 2018, 6:06am
AmericanBanking @AmericanBanking
Cytokinetics $CYTK Expected to Post Quarterly Sales of $5.57 Million https://t.co/Dks3WP9CVr #stocks
June 16th 2018, 3:06am
ZolmaxNews @ZolmaxNews
Cytokinetics $CYTK Expected to Post Quarterly Sales of $5.57 Million https://t.co/SA9cRutKuc
June 16th 2018, 3:06am
the_chart_life @the_chart_life
$CYTK Cytokinetics ...Breakout on a good increase in volume. https://t.co/PRUU4zCOgs
June 16th 2018, 12:06am
OlympiaReport @OlympiaReport
-$0.51 EPS Expected for Cytokinetics $CYTK This Quarter https://t.co/mu6xbCYmLq
June 14th 2018, 10:06am
AmericanBanking @AmericanBanking
Zacks: Analysts Anticipate Cytokinetics $CYTK Will Announce Earnings of -$0.51 Per Share https://t.co/AjypVSr7oC #stocks
June 14th 2018, 9:06am
dispatchtribune @dispatchtribune
Zacks: Analysts Anticipate Cytokinetics $CYTK Will Announce Earnings of -$0.51 Per Share https://t.co/6rqiuNsDEV
June 14th 2018, 9:06am
registrarjourn @registrarjourn
Zacks: Analysts Anticipate Cytokinetics $CYTK Will Announce Earnings of -$0.51 Per Share https://t.co/ScngQrHvbd
June 14th 2018, 9:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.